Trial Profile
A Randomized, Open-label, Single-dosing, 2x2 Crossover Study to Compare the Safety and Pharmacokinetics of CKD-390 Tablet (Tenofovir Disoproxil Aspartate) With Viread® Tablet (Tenofovir Disoproxil Fumarate) in Healthy Male Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 30 Jan 2016
Price :
$35
*
At a glance
- Drugs Tenofovir disoproxil aspartate (Primary) ; Tenofovir disoproxil fumarate
- Indications Hepatitis B
- Focus Pharmacokinetics
- Sponsors Chong Kun Dang
- 11 Jan 2016 Status changed from recruiting to completed, according to ClinicalTrials.gov record.
- 03 Nov 2015 New trial record